$6.51
-0.23-3.41%
At close: -
$6.70
0.192.92%
After Hours: 5:09 PM EDT
Comments
Loading...
Silence Therapeutics (NASDAQ:SLN) Stock, Earnings Estimates, EPS, And Revenue
Silence Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.750
Quarterly Revenue
$1.5M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$16.2M
Analyze the earnings history of Silence Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Silence Therapeutics (SLN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Silence Therapeutics (SLN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Silence Therapeutics (NASDAQ:SLN) reporting earnings?
Silence Therapeutics (SLN) is scheduled to report earnings on March 11, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Silence Therapeutics (NASDAQ:SLN)?
The Actual EPS was $-0.75, which missed the estimate of $0.00.
What were Silence Therapeutics’s (NASDAQ:SLN) revenues?
The Actual Revenue was $1.5M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.